Overview Dividends

(XHR) Xenia Hotels & Resorts - Ratings and Ratios

Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9840171030

Luxury Hotels, Upscale Resorts, Hotel Portfolio, Rooms

XHR EPS (Earnings per Share)

EPS Growth (3Y CAGR): -42.23%
EPS Trend (3Y Correlation): 11.6%

XHR Revenue

Revenue Growth (3Y CAGR): 6.69%
Revenue Trend (3Y Correlation): 44.0%

Risk via 10d forecast
Volatility	28.3%
Value at Risk 5%th	41.5%
Relative Tail Risk	-11.04%

Reward TTM
Sharpe Ratio	-0.05
Alpha	-20.61

Character TTM
Hurst Exponent	0.544
Beta	1.284
Beta Downside	1.265

Drawdowns 3y
Max DD	42.47%
Mean DD	13.47%
Median DD	13.05%

Description: XHR Xenia Hotels & Resorts November 13, 2025

Xenia Hotels & Resorts, Inc. (NYSE:XHR) is a self-advised, self-administered REIT that concentrates on luxury and upper-upscale hotels and resorts located in the top 25 U.S. lodging markets and premier leisure destinations. The portfolio comprises 30 properties, totaling 8,868 rooms across 14 states, and is operated or licensed by major brands such as Marriott, Hyatt, Fairmont, Kimpton, Loews, Hilton, and The Kessler Collection.

As of Q3 2024, Xenia’s average occupancy hovered around 71%, with a RevPAR growth of 4.2% year-over-year, reflecting the rebound in discretionary travel and strong demand for upscale accommodations. The REIT’s weighted-average ADR sits near $210, benefitting from a 6% annual increase in corporate travel budgets and a robust leisure-to-business travel mix. Forward-looking, the sector remains sensitive to macro-drivers like consumer confidence, inflation-adjusted discretionary spending, and the trajectory of the Federal Reserve’s interest-rate policy, which directly impacts cap-rate compression and refinancing risk.

For a deeper dive into XHR’s valuation metrics and scenario analysis, you might find ValueRay’s interactive dashboards useful.

XHR Stock Overview

Market Cap in USD	1,294m
Sub-Industry	Hotel & Resort REITs
IPO / Inception	2015-02-04
Return 12m vs S&P 500	-14.8%
Analyst Rating	3.71 of 5

XHR Dividends

Dividend Yield	3.84%
Yield on Cost 5y	4.80%
Yield CAGR 5y	14.94%
Payout Consistency	74.1%
Payout Ratio	69.2%

XHR Growth Ratios

CAGR 3y	1.06%
CAGR/Max DD Calmar Ratio	0.03
CAGR/Mean DD Pain Ratio	0.08
Current Volume	831.4k
Average Volume	932.2k

Piotroski VR‑10 (Strict, 0-10) 4.5

Net Income (63.0m TTM) > 0 and > 6% of Revenue (6% = 64.5m TTM)

FCFTA 0.02 (>2.0%) and ΔFCFTA 0.97pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)

NWC/Revenue 9.07% (prev 14.44%; Δ -5.37pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)

CFO/TA 0.06 (>3.0%) and CFO 172.9m > Net Income 63.0m (YES >=105%, WARN >=100%)

Net Debt (1.25b) to EBITDA (238.8m) ratio: 5.24 <= 3.0 (WARN <= 3.5)

Current Ratio 1.88 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)

Outstanding Shares last Quarter (101.6m) change vs 12m ago -0.75% (target <= -2.0% for YES)

Gross Margin 25.32% (prev 24.95%; Δ 0.37pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)

Asset Turnover 37.19% (prev 35.29%; Δ 1.90pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)

Interest Coverage Ratio 1.30 (EBITDA TTM 238.8m / Interest Expense TTM 83.3m) >= 6 (WARN >= 3)

Altman Z'' -0.66

(A) 0.03 = (Total Current Assets 208.2m - Total Current Liabilities 110.7m) / Total Assets 2.88b

(B) -0.22 = Retained Earnings (Balance) -636.5m / Total Assets 2.88b

(D) -0.39 = Book Value of Equity -635.2m / Total Liabilities 1.61b

Total Rating: -0.66 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 53.16

1. Piotroski 4.50pt = -0.50

2. FCF Yield 1.99% = 1.00

3. FCF Margin 4.72% = 1.18

4. Debt/Equity 1.17 = 1.85

5. Debt/Ebitda 5.24 = -2.50

6. ROIC - WACC (= -1.74)% = -2.17

7. RoE 5.11% = 0.43

8. Rev. Trend 43.99% = 3.30

9. EPS Trend 11.59% = 0.58

What is the price of XHR shares?

As of November 15, 2025, the stock is trading at USD 14.06 with a total of 831,439 shares traded.
Over the past week, the price has changed by +3.46%, over one month by +9.76%, over three months by +6.29% and over the past year by -2.36%.

Is Xenia Hotels & Resorts a good stock to buy?

Neither. Based on ValueRay´s Fundamental Analyses, Xenia Hotels & Resorts is currently (November 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 53.16 and therefor a neutral outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of XHR is around 13.40 USD . This means that XHR is currently overvalued and has a potential downside of -4.69%.

Is XHR a buy, sell or hold?

Xenia Hotels & Resorts has received a consensus analysts rating of 3.71. Therefor, it is recommend to hold XHR.

Strong Buy: 3
Buy: 1
Hold: 2
Sell: 0
Strong Sell: 1

What are the forecasts/targets for the XHR price?

Issuer	Target	Up/Down from current
Wallstreet Target Price	15	6.7%
Analysts Target Price	15	6.7%
ValueRay Target Price	14.6	3.8%

XHR Fundamental Data Overview November 01, 2025

Market Cap USD = 1.29b (1.29b USD * 1.0 USD.USD)
P/E Trailing = 20.2222
P/E Forward = 63.2911
P/S = 1.204
P/B = 1.0703
Beta = 1.735
Revenue TTM = 1.08b USD
EBIT TTM = 108.0m USD
EBITDA TTM = 238.8m USD
Long Term Debt = 1.42b USD (from longTermDebt, last quarter)
Short Term Debt = 2.28m USD (from shortTermDebt, last quarter)
Debt = 1.42b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.25b USD (from netDebt column, last quarter)
Enterprise Value = 2.55b USD (1.29b + Debt 1.42b - CCE 172.6m)
Interest Coverage Ratio = 1.30 (Ebit TTM 108.0m / Interest Expense TTM 83.3m)
FCF Yield = 1.99% (FCF TTM 50.7m / Enterprise Value 2.55b)
FCF Margin = 4.72% (FCF TTM 50.7m / Revenue TTM 1.08b)
Net Margin = 5.86% (Net Income TTM 63.0m / Revenue TTM 1.08b)
Gross Margin = 25.32% ((Revenue TTM 1.08b - Cost of Revenue TTM 802.9m) / Revenue TTM)
Gross Margin QoQ = 29.27% (prev 27.28%)
Tobins Q-Ratio = 0.89 (Enterprise Value 2.55b / Total Assets 2.88b)
Interest Expense / Debt = 1.54% (Interest Expense 21.9m / Debt 1.42b)
Taxrate = -2.30% (negative due to tax credits) (-1.38m / 59.9m)
NOPAT = 110.5m (EBIT 108.0m * (1 - -2.30%)) [negative tax rate / tax credits]
Current Ratio = 1.88 (Total Current Assets 208.2m / Total Current Liabilities 110.7m)
Debt / Equity = 1.17 (Debt 1.42b / totalStockholderEquity, last quarter 1.22b)
Debt / EBITDA = 5.24 (Net Debt 1.25b / EBITDA 238.8m)
Debt / FCF = 24.66 (Net Debt 1.25b / FCF TTM 50.7m)
Total Stockholder Equity = 1.23b (last 4 quarters mean from totalStockholderEquity)
RoA = 2.19% (Net Income 63.0m / Total Assets 2.88b)
RoE = 5.11% (Net Income TTM 63.0m / Total Stockholder Equity 1.23b)
RoCE = 4.07% (EBIT 108.0m / Capital Employed (Equity 1.23b + L.T.Debt 1.42b))
RoIC = 4.21% (NOPAT 110.5m / Invested Capital 2.63b)
WACC = 5.94% (E(1.29b)/V(2.72b) * Re(10.75%) + D(1.42b)/V(2.72b) * Rd(1.54%) * (1-Tc(-0.02)))
Discount Rate = 10.75% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.63%
[DCF Debug] Terminal Value 60.18% ; FCFE base≈39.7m ; Y1≈26.9m ; Y5≈13.1m
Fair Price DCF = 1.82 (DCF Value 174.0m / Shares Outstanding 95.8m; 5y FCF grow -37.64% → 3.0% )
EPS Correlation: 11.59 | EPS CAGR: -42.23% | SUE: 1.47 | # QB: 3
Revenue Correlation: 43.99 | Revenue CAGR: 6.69% | SUE: 2.68 | # QB: 2

Additional Sources for XHR Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle